By Ansha Hamid PharmD Candidate c/o 2027 The pharmaceutical industry has been shaken to its core and now faces significant changes with the rise of Amazon Pharmacy and Mark Cuban’s Cost Plus Drug Company (CPDC). Both entities have entered the market with a mission to provide more affordable prescription medications to consumers by increasing price…

By: Rebecca Sabzanov, PharmD Candidate c/o 2026 On July 15th, 2025, the FDA approved Kirsty, or insulin aspart-xjhz, as the first interchangeable biosimilar to insulin aspart. 1, 2 A biosimilar is a biologic that is very similar to the approved reference product and has no meaningful differences in safety, purity and potency. All insulin products…

By: Alba Dona, PharmD Candidate c/o 2027 Chronic obstructive pulmonary disease (COPD) is a disease caused by damage to the airways or other parts of the lung. The most common forms are emphysema and chronic bronchitis. The damage can lead to inflammation and make it harder to breathe.1 The most common symptoms of COPD are…

By: Aymon Choudhury, PharmD Candidate c/o 2027 Most people consider the emergency department (ED) a chaotic environment, where physicians and nurses scramble to efficiently treat patients under intense pressure. However, many are unaware of the significant contributions pharmacists make in this setting. In the fast-paced and unpredictable world of emergency medicine (EM), pharmacists bring specialized…